Rancho Mirage, CA1 Active Studies

Waldenstrom Macroglobulinemia Clinical Trials in Rancho Mirage, CA

Find 1 actively recruiting waldenstrom macroglobulinemia clinical trials in Rancho Mirage, CA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
111
Enrolling

Recruiting Waldenstrom Macroglobulinemia Studies in Rancho Mirage

About Waldenstrom Macroglobulinemia Clinical Trials in Rancho Mirage

Waldenstrom macroglobulinemia is a rare type of non-Hodgkin lymphoma where cancer cells produce large amounts of an abnormal protein called macroglobulin. It progresses slowly and may not require immediate treatment. Options include targeted therapy, chemotherapy, and plasmapheresis.

There are currently 1 waldenstrom macroglobulinemia clinical trials recruiting participants in Rancho Mirage, CA. These studies are seeking a combined 111 participants. Research is being sponsored by BeiGene. Clinical trial participation is free and participants receive study-related medical care at no cost.

Waldenstrom Macroglobulinemia Clinical Trials in Rancho Mirage — FAQ

Are there waldenstrom macroglobulinemia clinical trials in Rancho Mirage?

Yes, there are 1 waldenstrom macroglobulinemia clinical trials currently recruiting in Rancho Mirage, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rancho Mirage?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rancho Mirage research site will contact you about next steps.

Are clinical trials in Rancho Mirage free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rancho Mirage studies also compensate for your time and travel.

What waldenstrom macroglobulinemia treatments are being tested?

The 1 active trials in Rancho Mirage are testing new therapies including novel drugs, biologics, and treatment approaches for waldenstrom macroglobulinemia.

Data updated July 13, 2026 from ClinicalTrials.gov